{
  "docId": "019de073-255b-76bc-aa80-92d644ae851f",
  "docSlug": "6adc4199404f3567dc014a464fd017b2",
  "documentTitle": "Ginkgo | Mergers and Acquisitions Presentation Deck | 16 slides",
  "authorId": "ginkgo",
  "authorName": "Ginkgo Bioworks",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2022-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 16,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a 'before-after' style contrast in the headline to frame the acquisition's value proposition.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-255b-76bc-aa80-92d644ae851f/14",
  "deckHref": "/decks/019de073-255b-76bc-aa80-92d644ae851f",
  "deckJsonHref": "/decks/019de073-255b-76bc-aa80-92d644ae851f.json",
  "deckAnchorHref": "/decks/019de073-255b-76bc-aa80-92d644ae851f#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.85,
        "x": 0.06,
        "y": 0.43
      },
      "kind": "list",
      "text": "Lowers program costs for our customers by helping us achieve our Knight’s Law scaling targets - technology will help drive productivity and utilization, while allowing Ginkgo to manage our near-term operating cost structure",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a320df67-59f2-46a1-b1a0-d1b3ccebeeda",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.85,
        "x": 0.06,
        "y": 0.63
      },
      "kind": "list",
      "text": "Expect technology to contribute to improving probability of success for our customers: More robust data and analysis tools to design better strains and experiments; Lower cost enables more shots on goal for the same budget",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bfc340e6-0bc5-435e-8ddd-57ee021dae92",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.85,
        "x": 0.06,
        "y": 0.32
      },
      "kind": "list",
      "text": "Supports platform scaling efforts by contributing a world-class team and robust technology stack",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e5ef3715-1881-4b36-bf09-5e2f76d0431b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.85,
        "x": 0.06,
        "y": 0.82
      },
      "kind": "paragraph",
      "text": "We believe that together, we will be better able to build a strong base for biomanufacturing in the US and unlock the value of synthetic biology, one of the key technologies highlighted in the US Innovation & Competitiveness Act on the Senate floor this week",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4beaab5c-c48c-42b6-950d-406192be986b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.03,
        "y": 0.08
      },
      "kind": "title",
      "text": "Unlike the Bayer transaction, Zymergen is not contributing meaningful revenue, but we believe there is significant value in improving our technical capabilities and value proposition to customers",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b0d7e36f-ad1b-408a-899a-8ca62646e43d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 14,
      "from": 12,
      "beatId": "be2b0d07-104b-4683-8352-26cfffe6ccdb",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "Strategic technical value and financial benefits",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 14,
      "from": 6,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "b60f02bd-9c06-4c4a-9699-fedf96659a67",
      "evidence": "Implicit discussion of risks and opportunities",
      "position": 1,
      "objective": "What are the costs of not pursuing strategic acquisitions?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}